Therefore, the role of GABARAPL2 in GC may be diverse, potentially involving multiple pathways leading to poor GC prognosis, and more research is needed to discover its specific mechanisms of action in order to bring real benefits to GC patients. The gene discussed is GABARAPL2; the disease is gastric cancer.